Prospective Association Between C-Reactive Protein and Fatigue in the Coronary Artery Risk Development in Young Adults Study

[1]  M. Hotopf,et al.  Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment , 2009, Molecular Psychiatry.

[2]  J. Suls,et al.  Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis , 2009, Psychosomatic medicine.

[3]  M. Irwin,et al.  Cytokine gene polymorphisms and fatigue in breast cancer survivors: Early findings , 2008, Brain, Behavior, and Immunity.

[4]  J. Woods,et al.  Exacerbated fatigue and motor deficits in interleukin-10-deficient mice after peripheral immune stimulation. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[5]  S. Ancoli-Israel,et al.  Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  L. Doornen,et al.  Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents , 2007, Brain, Behavior, and Immunity.

[7]  G. Pagnoni,et al.  Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy , 2007, Neuropsychopharmacology.

[8]  I. Hickie,et al.  Postinfective fatigue syndrome is not associated with altered cytokine production. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  M. Netea,et al.  Increased voluntary exercise in mice deficient for tumour necrosis factor‐α and lymphotoxin‐α , 2007, European journal of clinical investigation.

[10]  L. Natarajan,et al.  The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review , 2007, Brain, Behavior, and Immunity.

[11]  D. Jacobs,et al.  Physical activity in young adults and incident hypertension over 15 years of follow-up: the CARDIA study. , 2007, American journal of public health.

[12]  J. Ricci,et al.  Fatigue in the U.S. Workforce: Prevalence and Implications for Lost Productive Work Time , 2007, Journal of occupational and environmental medicine.

[13]  Shelley E. Taylor,et al.  Relationship of Early Life Stress and Psychological Functioning to Adult C-Reactive Protein in the Coronary Artery Risk Development in Young Adults Study , 2006, Biological Psychiatry.

[14]  J. E. Cunnick,et al.  Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of β-blockers, BMI, and psychosocial factors in older adults , 2006, Brain, Behavior, and Immunity.

[15]  M. Irwin,et al.  Inflammatory Biomarkers for Persistent Fatigue in Breast Cancer Survivors , 2006 .

[16]  S. Gold,et al.  Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  G. Pagnoni,et al.  Anterior Cingulate Activation and Error Processing During Interferon-Alpha Treatment , 2005, Biological Psychiatry.

[18]  C. Carlson,et al.  Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. , 2005, American journal of human genetics.

[19]  Michael Marmot,et al.  Cohort Profile: the Whitehall II study. , 2005, International journal of epidemiology.

[20]  F. Weber,et al.  Cytokine mRNA expression in patients with multiple sclerosis and fatigue , 2004, Multiple sclerosis.

[21]  B. Nicklas,et al.  Effects of hypocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese postmenopausal women. , 2004, The Journal of clinical endocrinology and metabolism.

[22]  P. Ganz,et al.  Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. , 2004, Journal of the National Cancer Institute.

[23]  R. Lipton,et al.  Lost productive time and cost due to common pain conditions in the US workforce. , 2003, JAMA.

[24]  C. Nemeroff,et al.  Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. , 2003, The American journal of psychiatry.

[25]  David Morganstein,et al.  Cost of lost productive work time among US workers with depression. , 2003, JAMA.

[26]  I. Todd,et al.  Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short‐term cultured blood mononuclear cells , 2003, Clinical and experimental immunology.

[27]  Yu-ling,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[28]  Paul H. Black,et al.  Stress and the inflammatory response: A review of neurogenic inflammation , 2002, Brain, Behavior, and Immunity.

[29]  Patricia A. Ganz,et al.  Fatigue and Proinflammatory Cytokine Activity in Breast Cancer Survivors , 2002, Psychosomatic medicine.

[30]  C. Nemeroff,et al.  Neurobehavioral Effects of Interferon-α in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom Dimensions , 2002, Neuropsychopharmacology.

[31]  Laura Cousino Klein,et al.  Predictors of Fatigue in Healthy Young Adults: Moderating Effects of Cigarette Smoking and Gender , 2002, Biological research for nursing.

[32]  S. West,et al.  A comparison of methods to test mediation and other intervening variable effects. , 2002, Psychological methods.

[33]  K. Huppler Hullsiek,et al.  Assessing the utility of five domains in SF-12 Health Status Questionnaire in an AIDS clinical trial , 2002, AIDS.

[34]  M. Amato,et al.  Quality of life in multiple sclerosis: the impact of depression, fatigue and disability , 2001, Multiple sclerosis.

[35]  David H. Miller,et al.  Fatigue is not associated with raised inflammatory markers in multiple sclerosis , 2001, Neurology.

[36]  G. Curt,et al.  Impact of fatigue on quality of life in oncology patients. , 2000, Seminars in hematology.

[37]  J. Danesh,et al.  Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.

[38]  J. Habbema,et al.  Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. , 2000, Statistics in medicine.

[39]  Daniel A. Powers,et al.  Statistical Methods for Categorical Data Analysis , 1999 .

[40]  R. Moss,et al.  TNF-α and Chronic Fatigue Syndrome , 1999, Journal of Clinical Immunology.

[41]  G. Lange,et al.  Changes in Immune Parameters Seen in Gulf War Veterans but Not in Civilians with Chronic Fatigue Syndrome , 1999, Clinical Diagnostic Laboratory Immunology.

[42]  P. Kind,et al.  Comparison of the MOS short form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis. , 1998, British journal of rheumatology.

[43]  G. Lyman,et al.  Measurement of Fatigue in Cancer Patients: Development and Validation of the Fatigue Symptom Inventory , 1998, Quality of Life Research.

[44]  J. Born,et al.  Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. , 1998, The Journal of clinical endocrinology and metabolism.

[45]  C. Ferrans,et al.  The quality of life of persons with chronic fatigue syndrome. , 1997, The Journal of nervous and mental disease.

[46]  J. Stradling,et al.  A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies? , 1997, Journal of public health medicine.

[47]  A. Komaroff,et al.  Interleukin-1β, Interleukin-1 Receptor Antagonist, and Soluble Interleukin-1 Receptor Type II Secretion in Chronic Fatigue Syndrome , 1997, Journal of Clinical Immunology.

[48]  D. Buchwald,et al.  Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. , 1997, The Journal of rheumatology.

[49]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[50]  P Wallace,et al.  Population based study of fatigue and psychological distress , 1994, BMJ.

[51]  M. Tsang,et al.  Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. , 1991, Cytokine.

[52]  A. Valdini,et al.  Fatigue of unknown aetiology--a review. , 1985, Family practice.

[53]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[54]  R. W. Ball,et al.  Acute Phase Responses and Cytokine Secretion in Chronic Fatigue Syndrome , 2004, Journal of Clinical Immunology.

[55]  S. Sisto,et al.  Immunological Response in Chronic Fatigue Syndrome Following a Graded Exercise Test to Exhaustion , 2004, Journal of Clinical Immunology.

[56]  A. Starr,et al.  Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. , 1997, Journal of psychiatric research.

[57]  S B Hulley,et al.  CARDIA: study design, recruitment, and some characteristics of the examined subjects. , 1988, Journal of clinical epidemiology.